News

STEMREGEN Ranks No. 332 on Inc. 5000 With 1,017% Growth

Whitefish, Mont. – September 25, 2026 -- STEMREGEN, a maker of science-backed stem cell supplements, has landed at No. 332 on the 2026 Inc. 5000 list after posting 1,017% revenue growth over three years, far outpacing the list's 130% median.

Company secures third straight Inc. 5000 ranking as growth trajectory accelerates

STEMREGEN previously ranked No. 265 in 2025 and No. 1,765 in 2024, marking three consecutive years on the annual list of America's fastest-growing private companies. The 2026 ranking measures revenue growth from 2022 through 2025.

Los Angeles Orbit Unveils Brand, Signs Yaamava' as Founding Partner

Los Angeles – September 25, 2026 -- Los Angeles Orbit, the newest franchise in League One Volleyball (LOVB), unveiled its team name, logo and brand identity today at Intuit Dome ahead of its inaugural professional season.

Ohanian, Rae and James headline ownership group at Intuit Dome reveal

Team owners Alexis Ohanian, Issa Rae and Savannah James attended the unveiling alongside LOVB Commissioner Sandra Idehen and volleyball legend Misty May-Treanor. Players including Carli Lloyd, Kotoe Inoue, Annie Drews Schumacher, Madi Kingdon Rishel and Kathryn Boden joined the event, which also featured activist Malala Yousafzai.

MAYPHARM Launches HYALMASS AQUATOX, a Five-Active Aesthetic Formula

Seoul – September 26, 2026 -- MAYPHARM has announced the upcoming launch of HYALMASS AQUATOX, a new aesthetic formulation combining five high-interest active ingredients into a single product for the global cosmeceutical market.

MAYPHARM combines five actives into one formulation to meet multifunctional demand

The new product integrates PDRN, Exosomes, Botulinum Peptide, GHK-Cu, and Succinic Acid in one advanced skin solution. Botulinum Peptide is designed to support a smoother skin appearance, while GHK-Cu is studied for skin conditioning and regeneration. Succinic Acid is positioned for antioxidant activity, PDRN for skin regeneration and recovery, and Exosomes for advanced rejuvenation approaches.

Sunwest Bank Assumes $605M in Deposits in FDIC-Backed Nano Banc Deal

Irvine, Calif. – September 25, 2026 -- Sunwest Bank has acquired Nano Banc of Irvine, California, in an FDIC-assisted transaction that transfers approximately $605 million in deposits and $227 million in loans to the Sandy, Utah-based lender.

Regulators shut Nano Banc on September 25 before handing control to Sunwest

California's Department of Financial Protection and Innovation closed Nano Banc on Friday, September 25, placing it into FDIC receivership. The FDIC then entered an agreement with Sunwest Bank to acquire substantially all of Nano Banc's deposits and a portion of its assets, including the $605 million deposit book and $227 million loan portfolio.

MSE Gives MedStar Health $1.1M for D.C. Maternal, Pediatric Care

Washington, D.C. – September 25, 2026 -- Monumental Sports & Entertainment (MSE) has donated $1.1 million to MedStar Health, extending a five-year philanthropic commitment first pledged in 2024 to fund maternal, infant and pediatric care programs across Washington, D.C.

MSE and MedStar Health extend a five-year funding pledge into its third year

The gift continues annual support MSE committed in 2024 to expand access to specialized health services for birthing mothers and children in the District. Since 2019, MSE and The Leonsis Family have contributed more than $13 million to MedStar Health initiatives, including pediatric community health, COVID-19 response and sports medicine programs.

N95 Mask Market to Triple to $11.08B by 2034 on Safety Rules

Pune – – September 25, 2026 -- The global N95 mask market is projected to grow from $3.27 billion in 2025 to $11.08 billion by 2034, a 14.52% compound annual growth rate, according to Maximize Market Research.

North America dominates as major respirator makers expand capacity

North America held the largest regional share in 2025, driven by hospital demand, workplace safety mandates, and infection-control requirements. Manufacturers including 3M, Honeywell, Moldex-Metric, Cardinal Health, and Medline Industries maintain significant production presence in the region, supporting its lead position through continued investment in respiratory-protection capacity.

AI Clinical Trials Market to Hit $7.32B by 2034, 15.5% CAGR

Pune, India – September 25, 2026 -- The global AI in Clinical Trials Market is set to more than triple from USD 2 billion in 2025 to USD 7.32 billion by 2034, expanding at a 15.5% compound annual growth rate, according to Maximize Market Research.

Pharmaceutical firms accelerate AI adoption to cut trial delays

Pharmaceutical and biotechnology companies, along with contract research organizations, hospitals and research institutes, are deploying machine learning, natural language processing and deep learning to speed patient screening, cohort selection, trial design and large-scale data analysis. These tools are applied across Phase I, Phase II and Phase III trials for patient recruitment, safety monitoring, drug discovery and personalized medicine.

MagLev Aero Wins Dual DARPA Awards to Fast-Track Drone Propulsion

Boston – – September 25, 2026 -- MagLev Aero has secured concurrent contracts from the Defense Advanced Research Projects Agency under its Minimum Viable Product (MVP) and Embedded Entrepreneur Initiative (EEI) programs, providing non-dilutive funding to push its propulsion platform to Technology Readiness Level 6 (TRL-6).

DARPA funding targets flight-tested production for defense drones

The MVP award funds a full-scale, flight-relevant propulsion demonstration culminating in a TRL-6 test in an operational environment, aimed at de-risking adoption for airframers and OEMs building autonomous drones and crewed aircraft.

Webco Industries Posts Record FY2026 Net Income of $18.3 Million

Sand Springs, Okla. – September 25, 2026 -- Webco Industries, Inc. (OTC: WEBC) reported fiscal 2026 net income of $18.3 million, or $26.50 per diluted share, nearly double the $9.3 million, or $12.30 per diluted share, earned in fiscal 2025.

Annual net sales climb 14.8 percent to $670.9 million on stronger margins

Full-year net sales reached $670.9 million, up from $584.7 million in fiscal 2025. Gross profit for the year rose to $94.0 million, or 14.0 percent of net sales, compared with $66.8 million, or 11.4 percent, a year earlier. Income from operations increased to $28.0 million after $20.0 million in depreciation, versus $16.6 million after $19.0 million in depreciation in fiscal 2025.

Sabre Financial Secures 90% Tender for Debt, Sets Redemption

Southlake, Texas – September 25, 2026 -- Sabre Corporation (Nasdaq: SABR) disclosed that its indirect subsidiary, Sabre Financial Borrower, LLC, has secured tenders exceeding 90% of the aggregate principal amount outstanding on its targeted securities as of the September 25, 2026 early tender deadline, clearing the threshold required to force redemption of the remaining debt.

Over 90% acceptance triggers mandatory redemption of holdout bonds

Because more than 90% of the outstanding principal was validly tendered under the terms of the Indenture, Sabre Financial intends to issue a notice of redemption covering any securities that remain outstanding after the early settlement. The redemption price will match the Total Consideration offered in the tender, plus accrued and unpaid interest, with the redemption date expected on October 13, 2026.

Subscribe to News